NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,384,000 | +8.5% | 15,776 | +8.3% | 0.00% | – |
| Q4 2021 | $1,275,000 | -90.5% | 14,573 | -89.7% | 0.00% | -100.0% |
| Q4 2019 | $13,411,000 | -7.9% | 141,625 | -15.4% | 0.01% | -16.7% |
| Q3 2019 | $14,554,000 | -5.4% | 167,479 | -0.6% | 0.01% | 0.0% |
| Q2 2019 | $15,381,000 | -7.4% | 168,448 | -2.5% | 0.01% | -14.3% |
| Q1 2019 | $16,605,000 | +11.8% | 172,714 | -0.2% | 0.01% | 0.0% |
| Q4 2018 | $14,846,000 | -3.0% | 173,015 | -2.6% | 0.01% | +16.7% |
| Q3 2018 | $15,298,000 | +11.5% | 177,550 | -2.3% | 0.01% | 0.0% |
| Q2 2018 | $13,724,000 | -6.6% | 181,677 | -0.0% | 0.01% | 0.0% |
| Q1 2018 | $14,693,000 | -6.6% | 181,734 | -3.0% | 0.01% | -14.3% |
| Q4 2017 | $15,726,000 | -3.8% | 187,303 | -1.7% | 0.01% | 0.0% |
| Q3 2017 | $16,354,000 | -15.1% | 190,496 | -17.5% | 0.01% | -22.2% |
| Q2 2017 | $19,263,000 | -7.1% | 230,778 | -17.3% | 0.01% | -10.0% |
| Q1 2017 | $20,734,000 | +2.5% | 279,163 | +0.5% | 0.01% | 0.0% |
| Q4 2016 | $20,238,000 | -13.9% | 277,849 | -6.6% | 0.01% | -9.1% |
| Q3 2016 | $23,494,000 | -5.5% | 297,546 | -1.2% | 0.01% | -15.4% |
| Q2 2016 | $24,858,000 | +15.4% | 301,286 | +1.3% | 0.01% | +18.2% |
| Q1 2016 | $21,546,000 | -18.0% | 297,429 | -2.6% | 0.01% | -21.4% |
| Q4 2015 | $26,283,000 | -14.8% | 305,482 | -8.9% | 0.01% | -17.6% |
| Q3 2015 | $30,834,000 | -99.9% | 335,453 | -0.9% | 0.02% | 0.0% |
| Q2 2015 | $33,289,368,000 | -0.8% | 338,513 | -0.5% | 0.02% | 0.0% |
| Q1 2015 | $33,548,996,000 | +3.0% | 340,219 | -3.2% | 0.02% | 0.0% |
| Q4 2014 | $32,568,508,000 | +81800.4% | 351,484 | -16.8% | 0.02% | -19.0% |
| Q3 2014 | $39,766,000 | +5.0% | 422,470 | +0.9% | 0.02% | +5.0% |
| Q2 2014 | $37,889,000 | -99.9% | 418,519 | -4.6% | 0.02% | 0.0% |
| Q1 2014 | $37,300,824,000 | +245.3% | 438,730 | +226.5% | 0.02% | +233.3% |
| Q4 2013 | $10,802,188,000 | +3.7% | 134,389 | -1.1% | 0.01% | 0.0% |
| Q3 2013 | $10,419,059,000 | -1.7% | 135,824 | -9.4% | 0.01% | -14.3% |
| Q2 2013 | $10,601,763,000 | – | 149,933 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |